Log in or Sign up for Free to view tailored content for your specialty!
Nephrology News
Serology ‘significantly different’ between membranous vs. proliferative lupus nephritis
Proteinuria levels are not predictive of membranous lupus nephritis vs. proliferative lupus nephritis, according to data published in Rheumatology.
VIDEO: Newly defined syndrome is a ‘brilliant concept’ on stages of CVD risk
BOSTON — Cardiovascular-kidney-metabolic syndrome, or CKM, is a new term endorsed by the American Heart Association that reflects the interplay of metabolic and renal conditions that drive the risk for CVD.
Log in or Sign up for Free to view tailored content for your specialty!
Standard infection control prevented C. auris spread in dialysis facility
Standard infection prevention and control procedures prevented the spread of Candida auris at a Tennessee dialysis facility despite two patients there being colonized for up to 4 months during treatment, researchers reported.
FDA approves updated label for Lupkynis with long-term data, new monitoring guidelines
The FDA has approved an updated label for Lupkynis, an oral treatment for active lupus nephritis, that includes long-term safety and tolerability data, and eases the requirement for monthly kidney function assessments.
Most US adults estimated to have subclinical cardiovascular-kidney-metabolic syndrome
More than 70% of the overall U.S. population is estimated to have subclinical cardiovascular-kidney-metabolic syndrome, according to a research letter published in the Journal of the American College of Cardiology.
Nearly 25% of patients with chronic kidney disease meet gout criteria
Approximately 23% of patients with chronic kidney disease meet the criteria for gout, of whom 13% have uncontrolled gout and 36% have no formal gout diagnosis, according to data published in Gout, Urate, and Crystal Deposition Disease.
Team-based telehealth approach improves medication use in high-risk patients with diabetes
ATLANTA — A remote, team-based approach with immediate initiation of necessary medications improved guideline-directed medical therapy use at 6 months for patients with diabetes at high CV or renal risk, researchers reported.
FDA approves aprocitentan for treatment of hypertension in adults with uncontrolled BP
Idorsia announced that the FDA has approved aprocitentan, its antihypertensive drug, for treatment of hypertension in combination with other drugs in patients whose BP is not adequately controlled on other drugs.
Osteoarthritis more likely in patients with non-alcoholic fatty liver disease
Non-alcoholic fatty liver disease is an independent risk factor for osteoarthritis, according to data published in Arthritis Research & Therapy.
'You're not going crazy': Second annual primary care scorecard highlights critical issues
The results of the second annual national primary care scorecard suggest the field is facing major problems — poor funding and a diminishing workforce, among them — but increased attention on the issues may offer hope, according to experts.
-
Headline News
Expected drop in HIV care providers may signal potential shift to primary care physicians
November 11, 20242 min read -
Headline News
Q&A: What to know about surge of ‘walking pneumonia’ in children
November 09, 20244 min read -
Headline News
Racial gaps in preemptive living donor kidney transplant persist during last 2 decades
November 12, 20241 min read
-
Headline News
Expected drop in HIV care providers may signal potential shift to primary care physicians
November 11, 20242 min read -
Headline News
Q&A: What to know about surge of ‘walking pneumonia’ in children
November 09, 20244 min read -
Headline News
Racial gaps in preemptive living donor kidney transplant persist during last 2 decades
November 12, 20241 min read